Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study.

Jîtcă G, Gáll Z, Jîtcă CM, Buț MG, Májai E

Open source

DOI
10.3390/pharmaceutics16030403
Published
2024 Mar 15
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics16030403,
  title = {Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study.},
  author = {Jîtcă G and Gáll Z and Jîtcă CM and Buț MG and Májai E},
  year = {2024},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics16030403},
  url = {https://doi.org/10.3390/pharmaceutics16030403}
}

RIS

TY  - JOUR
TI  - Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study.
AU  - Jîtcă G
AU  - Gáll Z
AU  - Jîtcă CM
AU  - Buț MG
AU  - Májai E
PY  - 2024
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics16030403
UR  - https://doi.org/10.3390/pharmaceutics16030403
ER  - 

APA

G, J., Z, G., CM, J., MG, B., & E, M. (2024). Drug Repurposing of Metformin for the Treatment of Haloperidol-Related Behavior Disorders and Oxidative Stress: A Preliminary Study.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics16030403

Source records